OS5.7 First results of the randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact 1st recurrence grade II and III glioma.
| Image |  |
|---|---|
| Description | scientific article published on 21 September 2016 |
| Author/s |
author: Paul Mulholland |
| Publication date | September 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |